Latest filing published 28 May 2019 for Adamis Pharmaceuticals Corp, €9,182.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert B. Rothermel: trading record in brief
All filings by Robert B. Rothermel on record concern Adamis Pharmaceuticals Corp. Over a trading history stretching from 20 December 2006 to 24 May 2019, the count stands at 7 filings.
On the open market, the record shows 4 purchases worth €47k and 2 sales worth €26.1M. Taken together, the sales exceed the purchases by €26.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. In 2019 alone, the filings show 1 purchase and no sales.
The median purchase comes to €12k.
The newest entry dates from 28 May 2019: an open-market purchase of €9,182, in Adamis Pharmaceuticals Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert B. Rothermel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,500 shares@ US$1.58100.0% of flowCommon StockSEC:0001593968-19-001240:0Canonical exit: 22 Aug 2019 (T+90)
- 100,000 shares0Common StockSEC:0001387131-16-005710:0
- 5,000 shares@ US$3.30Common StockSEC:0001387131-15-002579:0Canonical exit: 11 Nov 2015 (T+90)
- 2,000 shares@ US$3.40Common StockSEC:0001387131-15-002579:1Canonical exit: 12 Nov 2015 (T+90)
- 5,500 shares@ US$4.03Common StockSEC:0001387131-14-003180:0Canonical exit: 27 Nov 2014 (T+90)
- 20,000 shares@ US$1,100.00Common StockSEC:0001144204-06-054696:0
- 15,000 shares@ US$825.00Common StockSEC:0001144204-06-054135:0
7 of 7 declarations